Biotech Alchemy convenes a closed room of capital allocators, pharma, med device, therapeutics, and diagnostics leadership, founders, and operators at the inflection points that matter. One day. No noise.
The patient is present throughout — advocacy woven into diligence, trial design, and the approval process. A portion of proceeds benefits patient advocacy organizations.